English
+38 068 889 89 89
00380689869898 (汉语)
00380930552240 (باللغة العربية)
00380930552240 (باللغة العربية)
+38 044 223 28 95
Contact us

Public funding of the research involving stem cells of embryos provoked a judicial struggle in the U.S.

The issue of state funding for studies involving stem cells of embryos provoked a judicial struggle in the U.S.

In particular, on August 23, the Federal Court of the District of Columbia decided to suspend public funding for the studies involving stem cells of the embryos. The Court issued a decision upon the joint action of representatives of religious organizations and scholars developing 'ethical' cell therapies, against the National Institutes of Health. The decision was issued because it was proved that such studies lead to embryos destruction. The decision would not be applied to privately funded experiments.

In fact, a court suspended the changes in the rules of research funding, which were introduced by Barack Obama administration in March 2009, when a ban on research involving stem cells of embryos, which was in force since 2001, was lifted. Because of the changes, it became possible to allocate public funds for research involving cells of human embryos that remained unused after infertility treatment involving extra corporal fertilization.

Because of the changes introduced by Barack Obama, in 2009, 22 new scientific projects were launched with a total budget of US$ 54mn, the continuation of which was under question after the court decision. The Obama administration appealed to the Federal Court of the District of Columbia with a request to cancel the decision, but the court refused to do it.

Nevertheless, on September 9, the Court of Appeals of the District of Columbia suspended the ban imposed by the Federal Court, on public funding of research with stem cells of embryos. The ban was set on hold until the final decision on the case is made, and by then the rules of financing of these studies introduced in 2009 are effective.


Fetal stem cells treatment results depend on: disease's severity, age of the patient, adherence for the medications and regime. Treatment results, presented on this site, are individual for each clinical case.